Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory Cytokines, Apoptotic, Tissue Injury and Remodeling Biomarkers in Children with Congenital Heart Disease

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The present study aims to evaluate specific biomarkers involved in congenital heart disease (CHD), and whether there is a significant differences between the levels of these biomarkers in the cyanotic CHD (CCHD) and acyanotic CHD (ACHD). We prospectively measured tumor necrosis factor (TNF-α), interleukin-6 (IL-6), C-reactive protein (CRP), vasoendothelial growth factor (VEGF), troponin T, creatin kinase MB (CKMB), and Caspase 3 levels in 120 consecutive children with CHD (60 cyanotic and 60 a cyanotic with age 1:4 years), and 30 healthy control children. Significant elevated levels of inflammatory markers; TNF-α, IL-6 and CRP was detected in CHD, with percentage increase in cyanotic than a cyanotic subjects as compared to the normal one. Apoptotic biomarker; caspase 3 showed also significant increases in CCHD than ACHD. In addition, tissue injury mechanisms included troponin T and CKMB, exhibited significant increase in cyanotic than a cyanotic CHD. The present results demonstrate also, significant enhancement in remodeling process (VEGF), in cyanotic than a cyanotic patients. Thus, it could be concluded that, the children with CCHD were shown to have elevated levels of inflammatory cytokines, caspase 3, troponin T, and CKMB as these biomarkers may implicated in cardiac functional status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kantor PF, Abraham JR, Dipchand AI, Benson LN, Redington AN. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol. 2010;55:1377–84.

    Article  PubMed  Google Scholar 

  2. Takaya J, Ikemoto Y, Teraguchi M, Nogi S, Kobayashi Y. Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatr Cardiol. 2000;21:378–81.

    Article  CAS  PubMed  Google Scholar 

  3. Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, Poole-Wilson PA, Coats AJ, Gatzoulis MA, Anker SD. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol. 2003;92(2): 188–93.

    Article  CAS  PubMed  Google Scholar 

  4. Hamada H, Ebata R, Higashi K, Higeru Tateno S, Niwa K, Honda T, Yasukawa K, Terai M. Serum vascular endothelial growth factor in cyanotic congenital heart disease functionally contributes to endothelial cell kinetics in vitro. Int J Cardiol. 2012;120:66–71.

    Article  Google Scholar 

  5. Rakusan K, Cicutti N, Kolar F. Cardiac function, microvascular structure, and capillary hematocrit in hearts of polycythemic rats. Am J Physiol Heart Circ Physiol. 2001;281:H2425–31.

    CAS  PubMed  Google Scholar 

  6. Ratnasamy C, Kinnamon DD, Lipshultz SE, Rusconi P. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J. 2008;155:527–33.

    Article  CAS  PubMed  Google Scholar 

  7. Kantor PF, Rusconi P. Biomarkers in pediatric heart failure: their role in diagnosis and evaluating disease progression. Prog Pediatr Cardiol. 2011;31(1):53–7.

    Article  Google Scholar 

  8. Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implication in vascular disorders. Lupus. 1998;7(Suppl 2):S120–5.

    Article  CAS  PubMed  Google Scholar 

  9. Cadroy Y, Diquelou A, Dupouy D, Bossavy JP, Sakariassen KS, Sie P. The thrombomodulin protein C/protein S anticoagulant pathway modulates the thrombogenic properties of the normal resting and stimulated endothelium. Arterioscler Thromb Vasc Biol. 1997;17(Suppl 2):520–7.

    Article  CAS  PubMed  Google Scholar 

  10. Horigome H, Murakami T, Isobe T, Nagasawa T, Matsui A. Soluble P-selectin and thrombomodulin-protein C-protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis. Int J Cardiol. 2003;116:e74–5.

    Google Scholar 

  11. Kardys I, Knetsch AM, Bleumink GS. C-reactive protein and risk of heart failure. The Rotterdam study. Am Heart J. 2006;152:514–20.

    Article  CAS  PubMed  Google Scholar 

  12. Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 2000;117:1706–12.

    Article  CAS  PubMed  Google Scholar 

  13. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJS, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:1838–42.

    Article  CAS  PubMed  Google Scholar 

  14. Hasper D, Hummel M, Kleber FX, Reindl I, Volk HD. Systemic inflammation in patients with heart failure. Eur Heart J. 1998;19:761–5.

    Article  CAS  PubMed  Google Scholar 

  15. Adimoolam S, Cooke JP. Endothelium-derived nitric oxide: an antiatherogenic molecule. In: Panza JA, Camnon RO, editors. Endothelium, NO, and atherosclerosis. Armonk: Futura Publishing; 1999. p. 257–67.

    Google Scholar 

  16. Fyfe A, Perloff JK, Niwa K, Child JS, Miner PD. Cyanotic congenital heart disease and coronary artery atherogenesis. Am J Cardiol. 2005;96:283–90.

    Article  PubMed  Google Scholar 

  17. Paniagua OA, Bryant MB, Panza JA. Role of endothelial nitric oxide in shear stress-induced vasodilatation of human microvasculature. Circulation. 2001;103:1752–8.

    Article  CAS  PubMed  Google Scholar 

  18. Bristow MR. Tumor necrosis factor-α and cardiomyopathy. Circulation. 1998;97:1340–1.

    Article  CAS  PubMed  Google Scholar 

  19. Best PJM, Hasdai D, Sangiorgi G, Schwartz R, Holmes DR Jr, Simari RD, Lerman A. Apoptosis: basic concepts and implications in coronary artery disease. Arterioscler Thromb Vasc Biol. 1999;19:14–22.

    Article  CAS  PubMed  Google Scholar 

  20. Yue T, Ohlstein EH, Ruffolo RR. Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases. Biol Sci. 1999;12:474–9.

    Google Scholar 

  21. Perloff JK, Rosove MH, Sietsema KE, Territo MC. Cyanotic congenital heart disease: a multisystem disorder. In: Perloff JK, Child JS, editors. Congenital heart disease in adults. Philadelphia: Saunders WB Company; 1998. p. 199–226.

    Google Scholar 

  22. Arnal JF, Dinh-Xuan AT, Pueyo M. Endothelial derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci. 2011;55:1078–87.

    Article  Google Scholar 

  23. Adatia I, Barrow SE, Stratton P, Ritter JM, Haworth SG. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease. Br Heart J. 1993;69:179–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Tempe DK, Virmani S. Coagulation abnormalities in patients with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth. 2002;16:752–65.

    Article  PubMed  Google Scholar 

  25. Omland T, de Lemos JA, Sabatine MS. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Child Health Department, National Research Center, Dokki, Giza, Egypt

    Yasser E. Nassef

  2. Therapeutic Chemistry Department, National Research Center, Dokki, Giza, Egypt

    Manal A. Hamed & Hanan F. Aly

Authors
  1. Yasser E. Nassef
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manal A. Hamed
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanan F. Aly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hanan F. Aly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nassef, Y.E., Hamed, M.A. & Aly, H.F. Inflammatory Cytokines, Apoptotic, Tissue Injury and Remodeling Biomarkers in Children with Congenital Heart Disease. Ind J Clin Biochem 29, 145–149 (2014). https://doi.org/10.1007/s12291-013-0341-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-013-0341-0

Keywords

Search

Navigation